SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001453687-24-000091
Filing Date
2024-07-03
Accepted
2024-07-03 16:07:31
Documents
5
Period of Report
2024-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1720037243.html 3  
1 FORM 3 wk-form3_1720037243.xml 3 1661
2 EX-24 poamalik.htm EX-24 7901
3 GRAPHIC poamalik001.jpg GRAPHIC 248069
4 GRAPHIC poamalik002.jpg GRAPHIC 88738
5 GRAPHIC poamalik003.jpg GRAPHIC 38572
  Complete submission text file 0001453687-24-000091.txt   528379
Mailing Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878
Business Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878 617-923-1400
Cartesian Therapeutics, Inc. (Issuer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACCELERON PHARMA INC. 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Malik Kemal (Reporting) CIK: 0001797921 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37798 | Film No.: 241100111